Bhavatarini Vangamudi, PhD

Senior Director
Exo Therapeutics

Poster(s):

• W102 - A Novel Exosite Inhibitor that Selectively Reprograms TBK1-STING Pathway for Autoimmune Diseases
  Wednesday, June 19, 2024

  7:30 AM – 7:30 PM PT